163 related articles for article (PubMed ID: 3732527)
1. Hormone excretion during early pregnancy following spontaneous and clomiphene citrate-induced ovulation.
Strigini F; Collins WP; Whitehead MI; Benedetto Melis G; Fioretti P; Campbell S
Fertil Steril; 1986 Aug; 46(2):209-14. PubMed ID: 3732527
[TBL] [Abstract][Full Text] [Related]
2. The effect of conception on the concentration of urinary oestrone-3-glucuronide, LH/hCG and pregnanediol-3 alpha-glucuronide.
Branch CM; Collins PO; Kilpatrick MJ; Collins WP
Acta Endocrinol (Copenh); 1980 Feb; 93(2):228-33. PubMed ID: 7376791
[TBL] [Abstract][Full Text] [Related]
3. Excretion of estrone-3-glucuronide in urine in spontaneous and induced ovulatory cycles.
Khatkhatay MI; Sankolli GM; Meherji PK; Chowdhury V; Joshi UM
Int J Fertil; 1988; 33(3):181-7. PubMed ID: 2899564
[TBL] [Abstract][Full Text] [Related]
4. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
5. Urinary estrone glucuronide, pregnanediol glucuronide and human chorionic gonadotrophin in threatened abortion.
Ishwad PC; Chitlange SM; Joshi UM; Chowdhury V; Mehta AC
Int J Gynaecol Obstet; 1988 Aug; 27(1):107-11. PubMed ID: 2905284
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
8. The OVEIA assay, a simultaneous measurement of oestrone and pregnanediol glucuronides, for studying the treatment of infertility patients.
Anthony F; Aldrich C; Sharp NC; Smith EM; Masson GM; Dennis KJ
Hum Reprod; 1988 Oct; 3(7):870-2. PubMed ID: 3182977
[TBL] [Abstract][Full Text] [Related]
9. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
10. Pregnancy hormone metabolite patterns, pregnancy symptoms, and coffee consumption.
Lawson CC; LeMasters GK; Levin LS; Liu JH
Am J Epidemiol; 2002 Sep; 156(5):428-37. PubMed ID: 12196312
[TBL] [Abstract][Full Text] [Related]
11. The return to ovulation following early abortion: a comparison between vacuum aspiration and prostaglandin.
Cameron IT; Baird DT
Acta Endocrinol (Copenh); 1988 Jun; 118(2):161-7. PubMed ID: 3291533
[TBL] [Abstract][Full Text] [Related]
12. Urinary hormone levels at the time of ovulation and implantation.
Lasley BL; Stabenfeldt GH; Overstreet JW; Hanson FW; Czekala N; Munro C
Fertil Steril; 1985 Jun; 43(6):861-7. PubMed ID: 3996630
[TBL] [Abstract][Full Text] [Related]
13. Corpus luteum function and pregnancy rates with clomiphene citrate therapy: comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation.
Agarwal SK; Buyalos RP
Hum Reprod; 1995 Feb; 10(2):328-31. PubMed ID: 7769057
[TBL] [Abstract][Full Text] [Related]
14. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles.
Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH
Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724
[TBL] [Abstract][Full Text] [Related]
15. The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.
Collins WP; Collins PO; Kilpatrick MJ; Manning PA; Pike JM; Tyler JP
Acta Endocrinol (Copenh); 1979 Feb; 90(2):336-48. PubMed ID: 419920
[TBL] [Abstract][Full Text] [Related]
16. The luteal phase after hyperstimulation for in vitro fertilization.
Gronow MJ; Martin MJ; Hay D; Moro D; Brown JB
Ann N Y Acad Sci; 1985; 442():391-401. PubMed ID: 3160279
[TBL] [Abstract][Full Text] [Related]
17. Measurement of estrone-3-glucuronide and pregnanediol-3 alpha-glucuronide in early morning urine samples to monitor ovarian function.
Magini A; Pinzani P; Bolelli GF; Bassi F; Salerno R; Messeri G; Pazzagli M
J Biolumin Chemilumin; 1989 Jul; 4(1):567-74. PubMed ID: 2801241
[TBL] [Abstract][Full Text] [Related]
18. Induction of ovulation. An attempt to avoid complications.
Cox LW; Cox RI; Black TL
Am J Obstet Gynecol; 1968 Sep; 102(2):177-85. PubMed ID: 5675863
[No Abstract] [Full Text] [Related]
19. Correlation of ovarian follicle size and the urinary excretion of oestrone glucuronide, luteinizing hormone and pregnanediol glucuronide in spontaneous cycles.
Adekunle AO; Collins WP; Whitehead MI
Afr J Med Med Sci; 1988 Jun; 17(2):77-82. PubMed ID: 2843021
[TBL] [Abstract][Full Text] [Related]
20. Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function.
Yilmaz B; Kelekci S; Savan K; Oral H; Mollamahmutoglu L
Fertil Steril; 2006 Mar; 85(3):783-6. PubMed ID: 16500364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
